Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer
Clinical trial NCT00615602 · COMPLETED
Trial details
- NCT number
- NCT00615602
- Sponsor
- Hellenic Oncology Research Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2012-05-01
- Enrollment
- 489
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.